|
A Novel Multiplex ELISA Assay for Evaluating Patients With Microscopic Hematuria for Bladder Cancer
RECRUITINGSponsored by Cedars-Sinai Medical Center
Actively Recruiting
SponsorCedars-Sinai Medical Center
Started2016-12-30
Est. completion2029-02
Eligibility
Age18 Years – 90 Years
Locations6 sites
View on ClinicalTrials.gov →
NCT03193541
Summary
To improve upon the non-invasive detection of BCa by further validating a multiplex ELISA assay directed at a BCa-associated diagnostic signature in voided urine samples of patients with microscopic hematuria.
Eligibility
Age: 18 Years – 90 Years
Inclusion Criteria: * Age 18 years or older * Have documented or reported microscopic hematuria within 3 month of study enrollment * Willing and able to give written informed consent Exclusion Criteria (participants must not): * Have history of BCa * History of previous cancer (excluding basal and squamous cell skin cancer) * Have a known active urinary tract infection or urinary retention * Have active stone disease (renal or bladder) or renal insufficiency (creatinine \>2.0 mg/dL) * Have ureteral stents, nephrostomy tubes or bowel interposition * Have recent genitourinary instrumentation (within 10 days prior to signing consent) * Be unable or unwilling to complete the hematuria evaluation (i.e., cystoscopy and upper tract imaging)
Conditions2
Bladder CancerCancer
Locations6 sites
Cedars-Sinai Medical Center
Los Angeles, California, 90048
Hoag Memorial Hospital Presbyterian
Newport Beach, California, 92663
University of Rochester Medical Center
Rochester, New York, 14620
Natalie CarrollNatalie_Carroll@URMC.Rochester.edu
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
SponsorCedars-Sinai Medical Center
Started2016-12-30
Est. completion2029-02
Eligibility
Age18 Years – 90 Years
Locations6 sites
View on ClinicalTrials.gov →
NCT03193541